mannose has been researched along with proanthocyanidin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomez, CS; Jahromi, MS; Mure, A | 1 |
| Esteban-Fuertes, M; Gómez-Rodríguez, A; Luján-Galán, M; Méndez-Rubio, S; Rituman, G; Salinas-Casado, J; Vírseda-Chamorro, M | 1 |
1 review(s) available for mannose and proanthocyanidin
| Article | Year |
|---|---|
UTIs in patients with neurogenic bladder.
Topics: Administration, Intravesical; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antibiotic Prophylaxis; Antioxidants; Ascorbic Acid; Botulinum Toxins, Type A; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Immunotherapy, Active; Mannose; Methenamine; Multiple Sclerosis; Neuromuscular Agents; Proanthocyanidins; Probiotics; Recurrence; Spinal Cord Injuries; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Catheters; Urinary Tract Infections | 2014 |
1 trial(s) available for mannose and proanthocyanidin
| Article | Year |
|---|---|
[Efficacy and safety of D-mannose (2 g), 24h prolonged release, associated with Proanthocyanidin (PAC), versus isolate PAC, in the management of a series of women with recurrent urinary infections.]
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mannose; Middle Aged; Proanthocyanidins; Recurrence; Treatment Outcome; Urinary Tract Infections | 2018 |